{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:17:04Z","timestamp":1772824624444,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602104"],"award-info":[{"award-number":["81602104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11596-025-00065-9","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T06:25:58Z","timestamp":1750055158000},"page":"616-625","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of Thymidine Phosphorylase and Sine Oculis Homeobox Homologue 1 on the Prognosis and Immune Microenvironment of Gastric Cancer"],"prefix":"10.1007","volume":"45","author":[{"given":"Miao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4030-9294","authenticated-orcid":false,"given":"Liu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"issue":"2","key":"65_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin."},{"issue":"3","key":"65_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrc3677","volume":"14","author":"SA Stacker","year":"2014","unstructured":"Stacker SA, Williams SP, Karnezis T, et al. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer. 2014;14(3):159\u2013172.","journal-title":"Nat Rev Cancer."},{"issue":"12","key":"65_CR3","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1002\/ijc.24702","volume":"125","author":"JP Sleeman","year":"2009","unstructured":"Sleeman JP, Thiele W. Tumor metastasis and the lymphatic vasculature. Int J Cancer. 2009;125(12):2747\u20132756.","journal-title":"Int J Cancer."},{"issue":"5","key":"65_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/jjco\/hyg042","volume":"33","author":"HJ Lee","year":"2003","unstructured":"Lee HJ, Kim YH, Kim WH, et al. Clinicopathological analysis for recurrence of early gastric cancer. Jpn J Clin Oncol. 2003;33(5):209\u2013214.","journal-title":"Jpn J Clin Oncol."},{"issue":"7","key":"65_CR5","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/sj.bjc.6605608","volume":"102","author":"M Tsujiura","year":"2010","unstructured":"Tsujiura M, Ichikawa D, Komatsu S, et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer. 2010;102(7):1174\u20131179.","journal-title":"Br J Cancer."},{"issue":"16","key":"65_CR6","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1158\/1078-0432.CCR-08-3203","volume":"15","author":"HY Lu","year":"2009","unstructured":"Lu HY, Klein RS, Schwartz EL. Antiangiogenic and antitumor activity of 6-(2-aminoethyl)amino-5-chlorouracil, a novel small-molecule inhibitor of thymidine phosphorylase, in combination with the vascular endothelial growth factor-trap. Clin Cancer Res. 2009;15(16):5136\u20135144.","journal-title":"Clin Cancer Res."},{"issue":"3","key":"65_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S1470-2045(05)01766-3","volume":"6","author":"M Toi","year":"2005","unstructured":"Toi M, Atiqur Rahman M, Bando H, et al. Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment. Lancet Oncol. 2005;6(3):158\u2013166.","journal-title":"Lancet Oncol."},{"issue":"21","key":"65_CR8","doi-asserted-by":"publisher","first-page":"10473","DOI":"10.18632\/oncotarget.2242","volume":"5","author":"S Tabata","year":"2014","unstructured":"Tabata S, Ikeda R, Yamamoto M, et al. Thymidine phosphorylase activates NF\u03baB and stimulates the expression of angiogenic and metastatic factors in human cancer cells. Oncotarget. 2014;5(21):10473\u201310485.","journal-title":"Oncotarget."},{"issue":"82\u201383","key":"65_CR9","first-page":"418","volume":"55","author":"M Haraguchi","year":"2008","unstructured":"Haraguchi M, Komuta K, Ueda T, et al. Prognostic significance of the serum thymidine phosphorylase levels in venous blood drainage specimens in patients with colorectal cancer. Hepatogastroenterology. 2008;55(82-83):418\u2013421.","journal-title":"Hepatogastroenterology."},{"issue":"9","key":"65_CR10","first-page":"1357","volume":"31","author":"K Katsumata","year":"2004","unstructured":"Katsumata K, Sumi T, Wada T, et al. Prognosis and efficacy of postoperative adjuvant chemotherapy in colorectal cancer correlates with nucleic acid metabolizing enzymes. Gan To Kagaku Ryoho. 2004;31(9):1357\u20131360.","journal-title":"Gan To Kagaku Ryoho."},{"issue":"10","key":"65_CR11","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1158\/1541-7786.MCR-08-0166","volume":"6","author":"EJ Yu","year":"2008","unstructured":"Yu EJ, Lee Y, Rha SY, et al. Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma. Mol Cancer Res. 2008;6(10):1554\u20131566.","journal-title":"Mol Cancer Res."},{"issue":"3","key":"65_CR12","first-page":"321","volume":"26","author":"Y Suda","year":"1999","unstructured":"Suda Y, Kuwashima Y, Shioya T, et al. The expression of thymidylate synthase and thymidine phosphorylase in the early-stage of gastric cancer. Gan To Kagaku Ryoho. 1999;26(3):321\u2013327.","journal-title":"Gan To Kagaku Ryoho."},{"issue":"6","key":"65_CR13","first-page":"1213","volume":"6","author":"Y Kakeji","year":"1999","unstructured":"Kakeji Y, Maehara Y, Shibahara K, et al. Heterogeneity and clinical role of thymidine phosphorylase activity in gastric cancer. Oncol Rep. 1999;6(6):1213\u20131216.","journal-title":"Oncol Rep."},{"issue":"19","key":"65_CR14","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.1158\/0008-5472.CAN-13-3598","volume":"74","author":"D Liu","year":"2014","unstructured":"Liu D, Li L, Zhang XX, et al. SIX1 promotes tumor lymphangiogenesis by coordinating TGF\u03b2 signals that increase expression of VEGF-C. Cancer Res. 2014;74(19):5597\u20135607.","journal-title":"Cancer Res."},{"issue":"5","key":"65_CR15","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1172\/JCI59858","volume":"122","author":"CA Wang","year":"2012","unstructured":"Wang CA, Jedlicka P, Patrick AN, et al. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J Clin Invest. 2012;122(5):1895\u20131906.","journal-title":"J Clin Invest."},{"issue":"2","key":"65_CR16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/cas.13905","volume":"110","author":"WX Song","year":"2019","unstructured":"Song WX, Ma J, Lei BB, et al. Sine oculis homeobox 1 promotes proliferation and migration of human colorectal cancer cells through activation of Wnt\/\u03b2-catenin signaling. Cancer Sci. 2019;110(2):608\u2013616.","journal-title":"Cancer Sci."},{"issue":"1","key":"65_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.yexmp.2014.05.007","volume":"97","author":"HX Lv","year":"2014","unstructured":"Lv HX, Cui AL, Sun FD, et al. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma. Exp Mol Pathol. 2014;97(1):74\u201380.","journal-title":"Exp Mol Pathol."},{"issue":"8","key":"65_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/15384047.2018.1450116","volume":"19","author":"FX Li","year":"2018","unstructured":"Li FX, Zhao Y, Wei LJ, et al. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer. Cancer Biol Ther. 2018;19(8):695\u2013705.","journal-title":"Cancer Biol Ther."},{"key":"65_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104261","volume":"360","author":"SI Abrams","year":"2021","unstructured":"Abrams SI. Developmental pathways of myeloid-derived suppressor cells in neoplasia. Cell Immunol. 2021;360:104261.","journal-title":"Cell Immunol."},{"key":"65_CR20","doi-asserted-by":"publisher","first-page":"15179","DOI":"10.1038\/srep15179","volume":"5","author":"B Shang","year":"2015","unstructured":"Shang B, Liu Y, Jiang SJ, et al. Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep. 2015;5:15179.","journal-title":"Sci Rep."},{"key":"65_CR21","doi-asserted-by":"crossref","unstructured":"Rizvi NA, Hellmann MD, Snyder A, et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015;348(6230):124\u2013128.","DOI":"10.1126\/science.aaa1348"},{"issue":"9","key":"65_CR22","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","volume":"8","author":"SC Wei","year":"2018","unstructured":"Wei SC, Duffy CR, Allison JP. Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov. 2018;8(9):1069\u20131086.","journal-title":"Cancer Discov."},{"issue":"1","key":"65_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","volume":"18","author":"S Qin","year":"2019","unstructured":"Qin S, Xu LP, Yi M, et al. Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4. Mol Cancer. 2019;18(1):155.","journal-title":"Mol Cancer."},{"issue":"4","key":"65_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u2013408.","journal-title":"Methods."},{"key":"65_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.semcancer.2017.11.005","volume":"56","author":"B Ricciuti","year":"2019","unstructured":"Ricciuti B, Foglietta J, Bianconi V, et al. Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy. Semin Cancer Biol. 2019;56:87\u201399.","journal-title":"Semin Cancer Biol."},{"issue":"4","key":"65_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/PAT.0000000000000094","volume":"46","author":"XL Zhang","year":"2014","unstructured":"Zhang XL, Zheng ZL, Shin YK, et al. Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer. Pathology. 2014;46(4):316\u2013324.","journal-title":"Pathology."},{"issue":"28","key":"65_CR27","doi-asserted-by":"publisher","first-page":"44185","DOI":"10.18632\/oncotarget.9923","volume":"7","author":"L Huang","year":"2016","unstructured":"Huang L, Liu S, Lei Y, et al. Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection. Oncotarget. 2016;7(28):44185\u201344193.","journal-title":"Oncotarget."},{"key":"65_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biopha.2018.04.028","volume":"105","author":"C Yu","year":"2018","unstructured":"Yu C, Zhang B, Li YL, et al. SIX1 reduces the expression of PTEN via activating PI3K\/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma. Biomed Pharmacother. 2018;105:10\u201317.","journal-title":"Biomed Pharmacother."},{"issue":"2","key":"65_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/cas.13135","volume":"108","author":"T Nishimura","year":"2017","unstructured":"Nishimura T, Tamaoki M, Komatsuzaki R, et al. SIX1 maintains tumor basal cells via transforming growth factor-\u03b2 pathway and associates with poor prognosis in esophageal cancer. Cancer Sci. 2017;108(2):216\u2013225.","journal-title":"Cancer Sci."},{"issue":"2","key":"65_CR30","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3892\/ol.2016.4797","volume":"12","author":"SH Sun","year":"2016","unstructured":"Sun SH, Liu D, Deng YT, et al. SIX1 coordinates with TGF\u03b2 signals to induce epithelial-mesenchymal transition in cervical cancer. Oncol Lett. 2016;12(2):1271\u20131278.","journal-title":"Oncol Lett."},{"issue":"3","key":"65_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/carcin\/bgw121","volume":"38","author":"HW Xu","year":"2017","unstructured":"Xu HW, Zhang Y, Pe\u00f1a MM, et al. Six1 promotes colorectal cancer growth and metastasis by stimulating angiogenesis and recruiting tumor-associated macrophages. Carcinogenesis. 2017;38(3):281\u2013292.","journal-title":"Carcinogenesis."},{"issue":"6","key":"65_CR32","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/ijc.28755","volume":"136","author":"WJ Wu","year":"2015","unstructured":"Wu WJ, Ren ZQ, Li PH, et al. Six1: a critical transcription factor in tumorigenesis. Int J Cancer. 2015;136(6):1245\u20131253.","journal-title":"Int J Cancer."},{"issue":"8","key":"65_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/cbf.3361","volume":"36","author":"Y Xie","year":"2018","unstructured":"Xie Y, Jin P, Sun XR, et al. SIX1 is upregulated in gastric cancer and regulates proliferation and invasion by targeting the ERK pathway and promoting epithelial-mesenchymal transition. Cell Biochem Funct. 2018;36(8):413\u2013419.","journal-title":"Cell Biochem Funct."},{"key":"65_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103032","volume":"90","author":"S Tang","year":"2019","unstructured":"Tang S, Li YH, Bao YY, et al. Novel cytisine derivatives exert anti-liver fibrosis effect via PI3K\/Akt\/Smad pathway. Bioorg Chem. 2019;90:103032.","journal-title":"Bioorg Chem."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00065-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-025-00065-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00065-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T06:49:12Z","timestamp":1751870952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-025-00065-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["65"],"URL":"https:\/\/doi.org\/10.1007\/s11596-025-00065-9","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Ethics Committee of Tongji Hospital, Huazhong University of Science and Technology (Ethics Aprroval Number: TJ-C20210402). Informed consent was obtained from all patients for being included in the study.\u00a0The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}